Evaluation of the Efficacy and Safety of Griflow® Dual, a Pre-Set Two-Flow Infusion Device for Intravenous Immunoglobulin (Flebogamma® 5%) Administration

@article{Snchez2012EvaluationOT,
  title={Evaluation of the Efficacy and Safety of Griflow{\textregistered} Dual, a Pre-Set Two-Flow Infusion Device for Intravenous Immunoglobulin (Flebogamma{\textregistered} 5\%) Administration},
  author={Argentina S{\'a}nchez and Magdalena {\'A}lvarez and M. A. Bustillo and M. C. Garc{\'i}a and Margarita Mu{\~n}oz and C. Pacios and Lorena Pizarroso and M. Rubio and Nuria Rodr{\'i}guez},
  journal={The Journal of Vascular Access},
  year={2012},
  volume={13},
  pages={101 - 107}
}
Purpose A single center, prospective study was performed to assess the efficacy and safety of Griflow® Dual–-a gravity-fed device for intravenous delivery of human immunoglobulin Flebogamma®. Methods A total of 2 infusions in 2 visits per patient were assessed using G2 and G3 Griflow® Dual models that provide different flow rates adjusted to the patient's weight. To follow the most common method of intravenous immunoglobulin administration, infusion through the two-way device commenced with the… Expand

References

SHOWING 1-10 OF 20 REFERENCES
In vivo accuracy of gravity-flow i.v. infusion systems.
Risks associated with the use of intravenous immunoglobulin.
Safety of IGIV therapy and infusion-related adverse events
Immune globulin IV therapy: optimizing care of patients in the oncology setting.
Insights from the sharp end of intravenous medication errors: implications for infusion pump technology
Who is responsible for the safety of infusion devices? It’s high time for action!
  • K. Taxis
  • Medicine
  • Quality and Safety in Health Care
  • 2005
Developing Practice Guidelines for the Administration of Intravenous Immunoglobulin
Setting up and priming an intravenous infusion.
...
1
2
...